<SEC-DOCUMENT>0000950142-15-000742.txt : 20150414
<SEC-HEADER>0000950142-15-000742.hdr.sgml : 20150414
<ACCEPTANCE-DATETIME>20150414201439
ACCESSION NUMBER:		0000950142-15-000742
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150414
FILED AS OF DATE:		20150414
DATE AS OF CHANGE:		20150414

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Seachaid Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001639140
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		15770344

	BUSINESS ADDRESS:	
		STREET 1:		801 CAPITOLA DRIVE, SUITE 5
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27713
		BUSINESS PHONE:		919-354-1800

	MAIL ADDRESS:	
		STREET 1:		801 CAPITOLA DRIVE, SUITE 5
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27713

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Purcell Dennis J
		CENTRAL INDEX KEY:			0001297291

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		15770345

	MAIL ADDRESS:	
		STREET 1:		AUXILIUM PHARMACEUTICALS, INC.
		STREET 2:		160 WEST GERMANTOWN PIKE
		CITY:			NORRISTOWN
		STATE:			PA
		ZIP:			19401

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SCHIFF ANDREW N
		CENTRAL INDEX KEY:			0001172252

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		15770346

	MAIL ADDRESS:	
		STREET 1:		PLANET ZANETT INC
		STREET 2:		135 E 57TH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER NAME:	
		FORMER CONFORMED NAME:	SCHIFF DR DREW
		DATE OF NAME CHANGE:	20020426

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			AISLING CAPITAL PARTNERS LLC
		CENTRAL INDEX KEY:			0001376171
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		15770347

	BUSINESS ADDRESS:	
		STREET 1:		888 SEVENTH AVENUE
		STREET 2:		30TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106
		BUSINESS PHONE:		(212) 651-6380

	MAIL ADDRESS:	
		STREET 1:		888 SEVENTH AVENUE
		STREET 2:		30TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			AISLING CAPITAL PARTNERS, LP
		CENTRAL INDEX KEY:			0001376172
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		15770348

	BUSINESS ADDRESS:	
		STREET 1:		888 SEVENTH AVENUE
		STREET 2:		30TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106
		BUSINESS PHONE:		(212) 651-6380

	MAIL ADDRESS:	
		STREET 1:		888 SEVENTH AVENUE
		STREET 2:		30TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Aisling Capital II LP
		CENTRAL INDEX KEY:			0001350778

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		15770349

	BUSINESS ADDRESS:	
		STREET 1:		88 SEVENTH AVE 30TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106

	MAIL ADDRESS:	
		STREET 1:		88 SEVENTH AVE 30TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>es1500485_3-cidara.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2015-04-14</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001610618</issuerCik>
        <issuerName>Cidara Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>CDTX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001350778</rptOwnerCik>
            <rptOwnerName>Aisling Capital II LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>888 7TH AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>30TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10106</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001376172</rptOwnerCik>
            <rptOwnerName>AISLING CAPITAL PARTNERS, LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>888 7TH AVENUE,</rptOwnerStreet1>
            <rptOwnerStreet2>30TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10106</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001376171</rptOwnerCik>
            <rptOwnerName>AISLING CAPITAL PARTNERS LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>888 7TH AVENUE,</rptOwnerStreet1>
            <rptOwnerStreet2>30TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10106</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001172252</rptOwnerCik>
            <rptOwnerName>SCHIFF ANDREW N</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>888 7TH AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>30TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10106</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001297291</rptOwnerCik>
            <rptOwnerName>Purcell Dennis J</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>888 7TH AVENUE,</rptOwnerStreet1>
            <rptOwnerStreet2>30TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10106</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001639140</rptOwnerCik>
            <rptOwnerName>Seachaid Pharmaceuticals, Inc.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O AISLING CAPITAL LLC</rptOwnerStreet1>
            <rptOwnerStreet2>888 7TH AVENUE, 30TH FL</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10106</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>703092</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Seachaid Pharmaceuticals, LLC.</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F4"/>
                    <footnoteId id="F5"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F2"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>351518</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Aisling Capital II, L.P.</value>
                    <footnoteId id="F3"/>
                    <footnoteId id="F4"/>
                    <footnoteId id="F5"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Shares of common stock, par value $0.0001 per share (the &quot;Common Shares&quot;) of Cidara Therapeutics, Inc. (the &quot;Issuer&quot;) are held directly by Seachaid Pharmaceuticals, LLC. (&quot;Seachaid&quot;).</footnote>
        <footnote id="F2">Shares of preferred stock, par value $0.0001 per share (the &quot;Preferred Shares&quot;) are convertible at any time, at the holder's election, and have no expiration date. Upon the consummation of the Issuer's initial public offering, the Preferred Shares will automatically convert into Common Shares on a 25.4-to-1 basis.</footnote>
        <footnote id="F3">The Preferred Shares are directly held by Aisling Capital II, LP (&quot;Aisling&quot;).</footnote>
        <footnote id="F4">The investment committee of Aisling holds sole voting and dispositive power over the Common Shares held by Seachaid and the Preferred Shares held by Aisling. Aisling is a majority-owner of Seachaid. Aisling Capital Partners LP (&quot;Aisling GP&quot;) is the general partner of Aisling and Aisling Capital Partners LLC (&quot;Aisling Partners&quot;) is the general partner of Aisling GP. The individual managing members (collectively, the &quot;Managers&quot;) of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling and Seachaid. (Cont'd in FN5)</footnote>
        <footnote id="F5">(Cont'd from FN4) Each of the Reporting Persons disclaims beneficial ownership of the Common Shares and Preferred Shares, except to the extent of such person's pecuniary interest. Mr. Elms has filed a separate Form 3 with respect to his beneficial ownership of the Common Shares and Preferred Shares. Following the closing of the Issuer's initial public offering, the Reporting Persons will no longer own more than 10% of the Issuer's Common Shares.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Aisling Capital II, LP, by /s/ Lloyd Appel</signatureName>
        <signatureDate>2015-04-14</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Aisling Capital Partners, LLC, by /s/ Lloyd Appel</signatureName>
        <signatureDate>2015-04-14</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Aisling Capital Partners, LP, by /s/ Lloyd Appel</signatureName>
        <signatureDate>2015-04-14</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Andrew N. Schiff</signatureName>
        <signatureDate>2015-04-14</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Dennis J. Purcell</signatureName>
        <signatureDate>2015-04-14</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Seachaid Pharmaceuticals, LLC, by /s/ Lloyd Appel</signatureName>
        <signatureDate>2015-04-14</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
